» Articles » PMID: 3342760

Regulation of Progesterone Receptor Messenger Ribonucleic Acid and Protein Levels in MCF-7 Cells by Estradiol: Analysis of Estrogen's Effect on Progesterone Receptor Synthesis and Degradation

Overview
Journal Endocrinology
Specialty Endocrinology
Date 1988 Mar 1
PMID 3342760
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

The human breast cancer cell line MCF-7 responds to estrogens with increased progesterone receptor (PR) levels. In this study, we use dense amino acid density shift analyses to address directly the question of whether estrogen increases PR levels in MCF-7 cells by altering rates of receptor synthesis and/or degradation. Using different concentrations of estradiol (E2), which achieve PR levels that are half-maximal (3 X 10(-11) M F2) or maximal (6 X 10(-11) M E2), we have done sucrose gradient density shift analyses using dense (15N, 13C, 2H) amino acid incorporation to study rates of PR synthesis and degradation. These studies reveal a nonlinear loss of preexisting normal density receptor with time. From kinetic modeling analyses, equivalent rates of degradation are estimated for PR whether maximal or half-maximal levels are maintained, indicating that the major effect of E2 on PR content is to increase the rate of PR synthesis while leaving the degradation rate unaltered. The E2-stimulated increase in PR protein is also associated with increased levels of PR mRNA, as demonstrated by the use of a human PR cDNA probe. These density shift data provide evidence that the increased PR levels after estrogen exposure in MCF-7 cells are the result of an increased rate of receptor synthesis, rather than modulation of the rate of receptor degradation.

Citing Articles

Fertility treatment is associated with multiple meningiomas and younger age at diagnosis.

Shahin M, Magill S, Dalle Ore C, Viner J, Peters P, Solomon D J Neurooncol. 2019; 143(1):137-144.

PMID: 30868355 PMC: 6486831. DOI: 10.1007/s11060-019-03147-6.


Sensitivity and Isoform Specificity of F-Fluorofuranylnorprogesterone for Measuring Progesterone Receptor Protein Response to Estradiol Challenge in Breast Cancer.

Salem K, Kumar M, Yan Y, Jeffery J, Kloepping K, Michel C J Nucl Med. 2018; 60(2):220-226.

PMID: 30030339 PMC: 8833853. DOI: 10.2967/jnumed.118.211516.


Insulin-like growth factor receptor and sphingosine kinase are prognostic and therapeutic targets in breast cancer.

Ochnik A, Baxter R BMC Cancer. 2017; 17(1):820.

PMID: 29207959 PMC: 5718000. DOI: 10.1186/s12885-017-3809-0.


Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness.

Rojas P, May M, Sequeira G, Elia A, Alvarez M, Martinez P J Natl Cancer Inst. 2017; 109(7).

PMID: 28376177 PMC: 6059180. DOI: 10.1093/jnci/djw317.


The association between reproductive and hormonal factors and ovarian cancer by estrogen-α and progesterone receptor status.

Shafrir A, Rice M, Gupta M, Terry K, Rosner B, Tamimi R Gynecol Oncol. 2016; 143(3):628-635.

PMID: 27720231 PMC: 5116396. DOI: 10.1016/j.ygyno.2016.09.024.